Omnicell (OMCL) Reports In-Line Q3 EPS; Announces $275M Acquisition of Aesynt

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. SPY
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Omnicell (OMCL) Reports In-Line Q3 EPS; Announces $275M Acquisition of Aesynt

Omnicell, Inc. to Acquire Aesynt for $275 Million

October 29, 2015 4:35 PM EDT

MOUNTAIN VIEW, Calif., Oct. 29, 2015 /PRNewswire/ -- Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced it has entered into a definitive agreement to acquire Aesynt Incorporated. The acquisition would create the broadest product portfolio in the industry with significant offerings in automated dispensing systems, central pharmacy robotics, IV robotics and enterprise analytics. The combined company would support approximately... More

Omnicell Achieves Record Revenue in the Third Quarter 2015

October 29, 2015 4:30 PM EDT

MOUNTAIN VIEW, Calif., Oct. 29, 2015 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2015. 

GAAP results: Revenue for the third quarter of 2015 was $125.2 million, up $12.4 million or 11.0% from the second quarter of 2015, and up $12.7 million or 11.3% from the third quarter of 2014. Revenue for the nine months ended September 30, 2015 was $354.2 million, up $34.9 million or 10.9% from the nine months ended September 30, 2014. 

Third quarter... More